DZ Bank Discount Zert SAX 27.09.2.../ DE000DJ2PVD9 /
27/06/2024 13:34:30 | Chg.+0.050 | Bid14:12:40 | Demandez à14:12:40 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
29.690EUR | +0.17% | 29.680 Bid taille: 10,000 |
29.730 Ask la taille: 10,000 |
STROEER SE + CO. KGA... | - - | 27/09/2024 | Call |
GlobeNewswire
14:27
Aeroflow Health Launches Personalized Nutrition Services, Harnessing the Power of Food to Improve He...
GlobeNewswire
14:26
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...
GlobeNewswire
14:18
Medicenna Therapeutics Reports Fiscal Year 2024 Financial Results and Operational Highlights
GlobeNewswire
14:15
The Chainsmokers and Bebe Rexha Headline The Challenge, Abercrombie & Fitch Co.’s Annual Festival an...
GlobeNewswire
14:13
Xylo Technologies: Charging Robotics Secures First Commercial Order for EV Wireless Charging Systems...
GlobeNewswire
14:12
Charging Robotics Secures First Commercial Order for EV Wireless Charging Systems in Automatic Car P...
GlobeNewswire
14:07
Global Study Finds Only 22% Effectively Using Gen AI Across All Business Functions
GlobeNewswire
14:05
Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
GlobeNewswire
14:04
Noom Introduces AI-Enabled Products to Enhance On-Demand Health Care and Interactive Coaching
GlobeNewswire
14:03
American Rare Earths to Receive A$10.7 Million (US$7.1 Million) of Grant Funding from State of Wyomi...
GlobeNewswire
14:02
Dawn Bates, Founder of Dawn Bates International Reaches the Finals for the Social Impact Award in Na...
GlobeNewswire
14:01
Redwood Feeds Snak-King’s Appetite for Transportation Innovation Amid Supply Chain Disruption
GlobeNewswire
14:00
HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities
GlobeNewswire
14:00
As Consumers’ Monthly Debt Loads Increase, Auto Lenders Must Adapt to Manage Risk, Increase Originat...
GlobeNewswire
14:00
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page